Seminars in Nephrology
Volume 29, Issue 3 , Pages 300-317 , May 2009

Hyponatremia: Case Vignettes

  • David B. Mount, MD

      Affiliations

    • Renal Divisions, Brigham and Women's Hospital and VA Boston Healthcare System: Harvard Medical School, Boston, MA
    • Corresponding Author InformationAddress reprint requests to David B. Mount, MD, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Room 540, 4 Blackfan Circle, Boston, MA 02215
    • ,
  • Thomas A. Krahn, MD

      Affiliations

    • Division of Kidney Disease and Hypertension, Brown University, Warren Alpert Medical School, Providence, RI

References 

  1. Verbalis JG, Berl T. Disorders of water balance. In:  Brenner BM editors. The Kidney. 8th ed.. Philadelphia, PA: Saunders; 2008;p. 459–546
  2. Berl T. Treating hyponatremia: damned if we do and damned if we don't. Kidney Int. 1990;37:1006–1018
  3. Berl T. Impact of solute intake on urine flow and water excretion. J Am Soc Nephrol. 2008;19:1076–1078
  4. Perianayagam A, Sterns RH, Silver SM, et al. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. Clin J Am Soc Nephrol. 2008;3:331–336
  5. Bagley SC, Yaeger D. Hyponatremia associated with bupropion, a case verified by rechallenge. J Clin Psychopharmacol. 2005;25:98–99
  6. Mewasingh L, Aylett S, Kirkham F, Stanhope R. Hyponatremia associated with lamotrigine in cranial diabetes insipidus. Lancet. 2000;356:656
  7. Hill AR, Uribarri J, Mann J, Berl T. Altered water metabolism in tuberculosis: role of vasopressin. Am J Med. 1990;88:357–364
  8. Smith J, Godwin-Austen R. Hypersecretion of anti-diuretic hormone due to tuberculous meningitis. Postgrad Med J. 1980;56:41–44
  9. Chung HM, Kluge R, Schrier RW, Anderson RJ. Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med. 1987;83:905–908
  10. Milionis HJ, Liamis GL, Elisaf MS. The hyponatremic patient: a systematic approach to laboratory diagnosis. CMAJ. 2002;166:1056–1062
  11. Liamis GL, Milionis HJ, Rizos EC, Siamopoulos KC, Elisaf MS. Mechanisms of hyponatraemia in alcohol patients. Alcohol Alcohol. 2000;35:612–616
  12. Sanghvi SR, Kellerman PS, Nanovic L. Beer potomania: an unusual cause of hyponatremia at high risk of complications from rapid correction. Am J Kidney Dis. 2007;50:673–680
  13. Musch W, Xhaet O, Decaux G. Solute loss plays a major role in polydipsia-related hyponatremia of both water drinkers and beer drinkers. Q J Med. 2003;96:421–426
  14. Thaler SM, Teitelbaum I, Berl T. “Beer potomania” in non-beer drinkers: effect of low dietary solute intake. Am J Kidney Dis. 1998;31:1028–1031
  15. Rosenbaum JD, Nelson WP, Strauss MB, Davis RK, Rossmeisl EC. Variation in the diuretic response to ingested water related to the renal excretion of solutes. J Clin Invest. 1953;32:394–404
  16. Rose BD. New approach to disturbances in the plasma sodium concentration. Am J Med. 1986;81:1033–1040
  17. Hilden T, Svendsen TL. Electrolyte disturbances in beer drinkers (A specific “hypo-osmolality syndrome.”). Lancet. 1975;2:245–246
  18. Davison JM, Shiells EA, Philips PR, Lindheimer MD. Serial evaluation of vasopressin release and thirst in human pregnancy (Role of human chorionic gonadotrophin in the osmoregulatory changes of gestation). J Clin Invest. 1988;81:798–806
  19. Hayslett JP, Katz DL, Knudson JM. Dilutional hyponatremia in pre-eclampsia. Am J Obstet Gynecol. 1998;179:1312–1316
  20. Dokmetas HS, Kilicli F, Korkmaz S, Yonem O. Characteristic features of 20 patients with Sheehan's syndrome. Gynecol Endocrinol. 2006;22:279–283
  21. Fichman MP, Vorherr H, Kleeman CR, Telfer N. Diuretic-induced hyponatremia. Ann Intern Med. 1971;75:853–863
  22. Sharabi Y, Illan R, Kamari Y, et al. Diuretic induced hyponatremia in elderly hypertensive women. J Hum Hypertens. 2002;16:631–635
  23. Friedman E, Shadel M, Halkin H, Farfel Z. Thiazide-induced hyponatremia (Reproducibility by single dose rechallenge and an analysis of pathogenesis). Ann Intern Med. 1989;110:24–30
  24. Berl T, Linas SL, Aisenbrey GA, Anderson RJ. On the mechanism of polyuria in potassium depletion (The role of polydipsia). J Clin Invest. 1977;60:620–625
  25. Morris RG, Hoorn EJ, Knepper MA. Hypokalemia in a mouse model of Gitelman's syndrome. Am J Physiol Renal Physiol. 2006;290:F1416–F1420
  26. Cesar KR, Magaldi AJ. Thiazide induces water absorption in the inner medullary collecting duct of normal and Brattleboro rats. Am J Physiol. 1999;277:F756–F760
  27. Kim GH, Lee JW, Oh YK, et al. Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel. J Am Soc Nephrol. 2004;15:2836–2843
  28. Clark BA, Shannon RP, Rosa RM, Epstein FH. Increased susceptibility to thiazide-induced hyponatremia in the elderly. J Am Soc Nephrol. 1994;5:1106–1111
  29. Rao R, Zhang MZ, Zhao M, et al. Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxygenase 2-dependent polyuria. Am J Physiol Renal Physiol. 2005;288:F642–F649
  30. Norregaard R, Jensen BL, Li C, et al. COX-2 inhibition prevents downregulation of key renal water and sodium transport proteins in response to bilateral ureteral obstruction. Am J Physiol Renal Physiol. 2005;289:F322–F333
  31. Plasencia YL, Cortes MB, Arencibia DM, et al. Esthesioneuroblastoma recurrence presenting as a syndrome of inappropriate antidiuretic hormone secretion. Head Neck. 2006;28:1142–1146
  32. Osterman J, Calhoun A, Dunham M, et al. Chronic syndrome of inappropriate antidiuretic hormone secretion and hypertension in a patient with olfactory neuroblastoma (Evidence of ectopic production of arginine vasopressin by the tumor). Arch Intern Med. 1986;146:1731–1735
  33. Cullen MJ, Cusack DA, O'Briain DS, Devlin JB, Kehely A, Lyons TA. Neurosecretion of arginine vasopressin by an olfactory neuroblastoma causing reversible syndrome of antidiuresis. Am J Med. 1986;81:911–916
  34. Renneboog B, Decaux G. Idiopathic hyponatremia in a young patient: look at the sinus. Am J Med. 2008;121:e5–e6
  35. Ma AT, Lei KI. Small cell neuroendocrine carcinoma of the ethmoid sinuses presenting with generalized seizure and syndrome of inappropriate antidiuretic hormone secretion: a case report and review of literature. Am J Otolaryngol. 2009;30:54–57
  36. Vasan NR, Medina JE, Canfield VA, Gillies EM. Sinonasal neuroendocrine carcinoma in association with SIADH. Head Neck. 2004;26:89–93
  37. List AF, Hainsworth JD, Davis BW, Hande KR, Greco FA, Johnson DH. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer. J Clin Oncol. 1986;4:1191–1198
  38. Ellison DH, Berl T. Clinical practice (The syndrome of inappropriate antidiuresis). N Engl J Med. 2007;356:2064–2072
  39. Ferlito A, Rinaldo A, Devaney KO. Syndrome of inappropriate antidiuretic hormone secretion associated with head neck cancers: review of the literature. Ann Otol Rhinol Laryngol. 1997;106:878–883
  40. Anpalahan M. Chronic idiopathic hyponatremia in older people due to syndrome of inappropriate antidiuretic hormone secretion (SIADH) possibly related to aging. J Am Geriatr. Soc. 2001;49:788–792
  41. Decaux G, Vandergheynst F, Bouko Y, Parma J, Vassart G, Vilain C. Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree. J Am Soc Nephrol. 2007;18:606–612
  42. Grantham JJ, Orloff J. Effect of prostaglandin E1 on the permeability response of the isolated collecting tubule to vasopressin, adenosine 3′,5′-monophosphate, and theophylline. J Clin Invest. 1968;47:1154–1161
  43. Fernandez-Llama P, Ecelbarger CA, Ware JA, et al. Cyclooxygenase inhibitors increase Na-K-2Cl cotransporter abundance in thick ascending limb of Henle's loop. Am J Physiol. 1999;277:F219–F226
  44. Sun R, Carlson NG, Hemmert AC, Kishore BK. P2Y2 receptor-mediated release of prostaglandin E2 by IMCD is altered in hydrated and dehydrated rats: relevance to AVP-independent regulation of IMCD function. Am J Physiol Renal Physiol. 2005;289:F585–F592
  45. Wharam PC, Speedy DB, Noakes TD, Thompson JM, Reid SA, Holtzhausen LM. NSAID use increases the risk of developing hyponatremia during an Ironman triathlon. Med Sci Sports Exerc. 2006;38:618–622
  46. Fraser CL, Arieff AI. Epidemiology, pathophysiology, and management of hyponatremic encephalopathy. Am J Med. 1997;102:67–77
  47. Ayus JC, Arieff AI. Pulmonary complications of hyponatremic encephalopathy (Noncardiogenic pulmonary edema and hypercapnic respiratory failure). Chest. 1995;107:517–521
  48. Kalantar-Zadeh K, Nguyen MK, Chang R, Kurtz I. Fatal hyponatremia in a young woman after ecstasy ingestion. Nat Clin Pract Nephrol. 2006;2:283–288quiz 9
  49. Siegel AJ, Verbalis JG, Clement S, et al. Hyponatremia in marathon runners due to inappropriate arginine vasopressin secretion. Am J Med. 2007;120:461e11-7
  50. Janicic N, Verbalis JG. Evaluation and management of hypo-osmolality in hospitalized patients. Endocrinol Metab Clin North Am. 2003;32:459–481vii
  51. Mohmand HK, Issa D, Ahmad Z, Cappuccio JD, Kouides RW, Sterns RH. Hypertonic saline for hyponatremia: risk of inadvertent overcorrection. Clin J Am Soc Nephrol. 2007;2:1110–1117
  52. Lauriat SM, Berl T. The hyponatremic patient: practical focus on therapy. J Am Soc Nephrol. 1997;8:1599–1607
  53. Soupart A, Penninckx R, Stenuit A, Perier O, Decaux G. Reinduction of hyponatremia improves survival in rats with myelinolysis-related neurologic symptoms. J Neuropathol Exp Neurol. 1996;55:594–601
  54. Soupart A, Penninckx R, Crenier L, Stenuit A, Perier O, Decaux G. Prevention of brain demyelination in rats after excessive correction of chronic hyponatremia by serum sodium lowering. Kidney Int. 1994;45:193–200
  55. Soupart A, Ngassa M, Decaux G. Therapeutic relowering of the serum sodium in a patient after excessive correction of hyponatremia. Clin Nephrol. 1999;51:383–386
  56. Oya S, Tsutsumi K, Ueki K, Kirino T. Reinduction of hyponatremia to treat central pontine myelinolysis. Neurology. 2001;57:1931–1932
  57. Goldszmidt MA, Iliescu EA. DDAVP to prevent rapid correction in hyponatremia. Clin Nephrol. 2000;53:226–229
  58. Smith TJ, Gill JC, Ambruso DR, Hathaway WE. Hyponatremia and seizures in young children given DDAVP. Am J Hematol. 1989;31:199–202
  59. Odeh M, Oliven A. Coma and seizures due to severe hyponatremia and water intoxication in an adult with intranasal desmopressin therapy for nocturnal enuresis. J Clin Pharmacol. 2001;41:582–584
  60. Pruthi RS, Kang J, Vick R. Desmopressin induced hyponatremia and seizures after laparoscopic radical nephrectomy. J Urol. 2002;168:187
  61. Dehoorne JL, Raes AM, van Laecke E, Hoebeke P, Vande Walle JG. Desmopressin toxicity due to prolonged half-life in 18 patients with nocturnal enuresis. J Urol. 2006;176:754–757discussion 7-8
  62. Rembratt A, Graugaard-Jensen C, Senderovitz T, Norgaard JP, Djurhuus JC. Pharmacokinetics and pharmacodynamics of desmopressin administered orally versus intravenously at daytime versus night-time in healthy men aged 55-70 years. Eur J Clin Pharmacol. 2004;60:397–402
  63. Fjellestad-Paulsen A, Hoglund P, Lundin S, Paulsen O. Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers. Clin Endocrinol (Oxf). 1993;38:177–182
  64. Diederich S, Franzen NF, Bahr V, Oelkers W. Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases. Eur J Endocrinol. 2003;148:609–617
  65. Raff H. Glucocorticoid inhibition of neurohypophysial vasopressin secretion. Am J Physiol. 1987;252:R635–R644
  66. Erkut ZA, Pool C, Swaab DF. Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons. J Clin Endocrinol Metab. 1998;83:2066–2073
  67. Saito T, Ishikawa SE, Ando F, Higashiyama M, Nagasaka S, Sasaki S. Vasopressin-dependent upregulation of aquaporin-2 gene expression in glucocorticoid-deficient rats. Am J Physiol Renal Physiol. 2000;279:F502–F508
  68. Wang W, Li C, Summer SN, et al. Molecular analysis of impaired urinary diluting capacity in glucocorticoid deficiency. Am J Physiol Renal Physiol. 2006;290:F1135–F1142
  69. Kamoi K, Tamura T, Tanaka K, Ishibashi M, Yamaji T. Hyponatremia and osmoregulation of thirst and vasopressin secretion in patients with adrenal insufficiency. J Clin Endocrinol Metab. 1993;77:1584–1588
  70. Agus ZS, Goldberg M. Role of antidiuretic hormone in the abnormal water diuresis of anterior hypopituitarism in man. J Clin Invest. 1971;50:1478–1489
  71. Shoji M, Kimura T, Ota K, et al. Cortical laminar necrosis and central pontine myelinolysis in a patient with Sheehan syndrome and severe hyponatremia. Intern Med. 1996;35:427–431
  72. Lasheen I, Doi SA, Al-Shoumer KA. Glucocorticoid replacement in panhypopituitarism complicated by myelinolysis. Med Princ Pract. 2005;14:115–117
  73. Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006;355:2099–2112
  74. Zeltser D, Rosansky S, van Rensburg H, Verbalis JG, Smith N. Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia. Am J Nephrol. 2007;27:447–457

 Disclosure: Dr. Mount reports lecture fees from Astellas Pharma, makers of conivaptan.

 Supported by National Institutes of Health grants (DK57708 and DK070756), the American Heart Association, and the Veterans Administration.

PII: S0270-9295(09)00059-X

doi: 10.1016/j.semnephrol.2009.04.001

Seminars in Nephrology
Volume 29, Issue 3 , Pages 300-317 , May 2009

Article Tools

* Image Usage & Resolution